ArticleMedicine international
Recent evidence on quality of life following total gastrectomy for gastric cancer: A scoping review.
Article in Medicine international. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
As survival rates improve following total gastrectomy for gastric cancer, quality of life (QoL) has become a critical assessment outcome alongside traditional oncological metrics. Both the short- and long-term course of recovery can be affected by post-gastrectomy syndromes and other post-operative outcomes; however, QoL remains underreported and underutilised in clinical evaluations. Herein, a scoping review of studies published after 2020 that assessed QoL following total gastrectomy for gastric cancer was performed, focusing on curative resections without additional major organ removal. Articles were identified through the PubMed, Scopus and EMBASE databases using combinations of key words related to gastrectomy, QoL and validated patient-reported outcome instruments. A total of nine studies met the inclusion criteria. The majority of functional outcomes (physical, role and emotional functioning) consistently declined at an early stage following the surgery, with recovery typically beginning after ~6 months. Key symptoms, particularly reflux and eating restrictions, remained variable and could persist for up to 2 years. Global QoL improved over time despite ongoing symptoms, suggesting a degree of psychosocial adjustment. Surgical approach and anastomotic technique had limited long-term impact, though minimally invasive methods have been reported to show modest short-term advantages. Despite its clinical importance, QoL remains an underused primary outcome in gastric cancer surgery. A stronger focus on standardised, patient-centred assessment could bridge the gap between technical success and meaningful recovery. Identifying the distinct course of QoL following total gastrectomy may facilitate its integration into surgical planning and care. To the best of our knowledge, this is the first scoping review to focus exclusively on QoL following total gastrectomy in the era of updated surgical guidelines, providing an up-to-date framework for improving patient outcomes.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.